Folate is vital for cell growth and development through its important role in one-carbon metabolism -an essential process in the synthesis of amino acids and nucleic acids. Folate pathway genes have been considered as therapeutic targets of drugs for the treatment of cancer and other diseases. Racial and ethnic disparities of folate metabolism and outcome of antifolate therapies have been reported. In this study, we evaluate the genetic regulation for expression and alternative splicing of folate related genes in HapMap lymphoblastoid cell lines (LCLs) of individuals of European and African descent. Materials & methods: Gene and exon level expression and alternative splicing of folate pathway genes were compared in LCLs derived from the Centre d'Etude du Polymorphisme Humain (CEPH) from Utah (CEU) and the Yoruba from Ibadan (YRI) using a permutation-based test. A genome-wide association study was performed to search for SNPs associated with folate pathway gene expressions and alternative splicing in the combined population samples. Results: A total of 52 folate pathway genes were evaluated in the ana lysis of which 46 were expressed in the LCLs. There were 12 genes (26%) with differential gene-level expression and 23 genes (50%) with differential alternative splicing for exons or UTRs between the CEU and the YRI (permutation p ≤ 0.05). The expression level of FPGS and the splicing indices of eight genes (ATP13A2, ASCC3L1, IFIH1, SMARCA5, SMARCA2, SETX, DDX52 and RUVBL2) were found to be associated with SNP genotypes in the combined populations (p < 3.2 × 10 -8 , Bonferroni corrected p < 0.05). Conclusion: Our study suggests that LCLs are an in vitro system suitable to evaluate the expression levels of folate pathway genes. The differential transcript-level expressions and the differentially alternative splicing events of exons or UTRs and associated SNP markers in 2 populations will enhance our understanding of the folate pathway and, thus, facilitate research in the areas of nutrition and folate metabolism.
ReseaRch aRticle
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines
Folates are vitamins essential to the development of the CNS and therefore deficiencies in folate can result in adverse effects in humans [1] . Prenatal folate supplementation reduces the risk of neural tube defects [2] and probably oral-facial clefts [3] . In adult life, folate deficiency has been known for decades to produce a characteristic form of anemia [4] . As a cofactor in the transfer of single carbon unit, folate is involved in the synthesis of both amino acids and nucleic acids [5] .
The understanding that folate is essential in cell growth and development [2] has led to the development of antifolates for use in inflammatory diseases (e.g., rheumatoid arthritis) [6, 7] and in the treatment of cancer [8] . Antifolate drugs such as methotrexate, lometrexol, pemetrexed, edatrexate, ralitrexed, nolatrexed and PT523 are folate antagonists that competitively inhibit the activity of some folate pathway enzymes including those encoded by the genes TYMS, DHFR, GART and ATIC [9, 10] . Methotrexate and pemetrexed are broad-spectrum agents with large interindividual variations in their pharmacokinetic profiles and side effects that include suppression of bone marrow function, manifested by neutropenia, thrombocyto penia and anemia. Researchers have developed clinical pharmacogenetic models to predict the outcome of patients treated with some antifolate drugs using the combined information of polymorphic variations of specific folate pathway genes and other clinical phenotypes [11] .
Novel gene-expression signatures have been identified to predict sensitivity to antifolate drug treatment [12] [13] [14] . Gene-expression signatures predicting the subtypes of acute lymphoblastic leukemia and the sensitivity to antifolate therapy have been reported [13, 14] . Gene expression can be evaluated as a quantitative phenotype and used in association studies to identify expression quantitative trait loci (eQTL), including SNPs [15] [16] [17] and copy-number variations [18] . Researchers have found an association between the methotrexate pathway gene SNPs and methotrexate-induced toxicity that is racespecific in patients with rheumatoid arthritis [6] . Furthermore, ethnic differences in serum and red blood cell folate concentration have been observed future science group ReseaRch aRticle Duan, Huang, Zhang et al. between Caucasian and African-Americans or Mexican-Americans [19] and between Northern and Southern Chinese populations [20] . The focus of this paper is to better understand interethnic differences in expression of folate related genes.
The International HapMap lymphoblastoid cell lines (LCLs) offer a unique resource for studying genetic variants associated with expression because extensive genotypic data is publicly available [21, 101] . In addition, we recently reported on expression differences in LCL samples derived from Europeans and Africans [17] . In the present study, we evaluated the expression of folate pathway genes in LCLs to ascertain their utility as a cellular model to evaluate sensitivity to antifolates. Specifically, we evaluated both transcriptlevel expression and alternative splicing in both the Centre d'Etude du Polymorphisme Humain (CEPH) from Utah (CEU) and the Yoruba from Ibadan (YRI) samples and carried out a genome-wide scan for the eQTLs of the genes whose expression or alternative splicing differed between the two populations.
Materials & methods n Selection of folate pathway genes
A list of the complete set of genes for folate biosynthesis and one-carbon pool by folate was obtained by querying the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database for these two pathways [102] .
n Cell lines
HapMap LCLs (30 CEU trios and 30 YRI trios) were purchased from Coriell Institute for Medical Research (NJ, USA). The details of maintenance are described elsewhere [16, 17, 103] .
n Gene expression evaluation
The Affymetrix GeneChip ® Human Exon 1.0 sense target (ST) array (Affymetrix, Inc., CA, USA) was used to evaluate the base line expression of over 17,000 genes in 176 HapMap CEU and YRI LCLs [16, 17, 22, 23] . Probes potentially affected by SNPs were removed before the data summarization procedures [17, 24] . Folate pathway genes with an average expression level greater than 25th quantile of the average expression values of 17,000 transcript clusters, which translates to mean log 2 transformed mRNA expression signals greater than 5.34, were defined as expressed in LCLs.
n Splicing index calculation
The splicing index (SI) represents the logtransformed normalized exon-level probeset intensities by the gene-level transcript cluster intensities in each sample.
where e i,j is the intensity of the jth probeset of the ith transcript cluster, g i is the intensity of the ith transcript cluster and SI i,j is the splicing index of the jth probeset of the ith transcript cluster [25] . A probeset with higher SI value means that the probeset-representing exon or UTR has higher occurrence in the various transcript isoforms of a gene, implying a better chance of being spliced for the exon or UTR in the gene transcripts and vice versa. Using a t-test-based Westfall-Young (WY) approach that adjusts for the correlations among trio members, we identified the differentially expressed genes and SIs between the CEU and the YRI samples. Because of the relatedness among family members, trios were permuted between the CEU and YRI samples. The permutation-adjusted p-value (permutation p < 0.05) was considered statistically significant. The adjusted p-values were calculated from 10,000 permutations using Permax 2.2, which was provided as a contributory library by Robert Gray in the R statistical software.
n SNPs associated with race-specific genes & probesets
The SNP genotypes for CEU and YRI populations were downloaded from the online HapMap database (release 22, nonredundant and rs_strand version) [104] . Altogether, 1.57 million common SNPs with minor allele frequencies of greater than 5% in each population and with no Mendelian inheritance transmission errors for the trios were used in the present study. Using the total association option in the Linkage Disequilibrium Analyses for Quantitative and Discrete Traits (QTDT) software [26] , the genome-wide association study was carried out in the combined CEU and YRI samples using race and sex as covariates. The tested phenotypes contained 12 differentially expressed genes and 60 differentially spliced probesets. To distinguish between local and distant association between a SNP and its associated genes or transcript isoforms, we chose to define a local SNP if its associated gene was within 4 Mb on either side of the gene; otherwise it was defined as distant. All genomic future science group Expression of the folate pathway genes ReseaRch aRticle positions used in the present study were based on National Center for Biotechnology Information (NCBI) Build 36.1.
n Validation of differential expression of SMARCA2 gene between populations
We randomly chose 30 unrelated CEU and 30 unrelated YRI cell lines n CEU: GM06985, GM06993, GM07022, G M0703 4, G M07055, G M07056 , GM07345, GM07357, GM11830, GM11832, GM11992, GM11993, GM12003, GM12005, GM12 0 0 6 , GM12 0 4 4, GM12 056 , GM12155, GM12717, GM12750, GM12751, GM12760, GM12761, GM12812, GM12813, GM12814, GM12873, GM12875, GM12891, GM12892; ReseaRch aRticle Duan, Huang, Zhang et al.
n YRI: GM18501, GM18502, GM18505, GM18507, GM18508, GM18517, GM18853, GM18856, GM18859, GM18861, GM18870, GM18912, GM19092, GM19101, GM19102, GM19131, GM19137, GM19140, GM19141, GM19153, GM19171, GM19172, GM19193, GM19203, GM19204, GM19206, GM19207, GM19209, GM19210, GM19239.
Total RNA was extracted using the RNeasy ® Mini kit (Qiagen Inc., CA, USA) following the manufacturer's protocol. RNA quality assessment and quantification were conducted using the optical spectrometry 260:280 nm ratio. Subsequently, mRNA was reverse transcribed to cDNA using Applied Biosystems High Capacity Reverse Transcription kit (Applied Biosystems, CA, USA). TaqMan ® Hs01030861_m1 probe was used for the evaluation of the differential expression of SMARCA2 gene. Expression measurements were performed on the Applied Biosystems 7500 real-time PCR system. Total reaction was carried out in 25 µl volume consisting 12.5 µl ABI SYBR ® Universal mix (Applied Biosystems), 1.5 µl primers along with 10 µl diluted cDNA. The thermocyler parameters were: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s/60°C for 1 min. Each cycle threshold (C t ) value obtained for each probeset of interest was quantified into relative expression levels of the control (human b2-microglobulin) using the relative standard curve method. Each standard curve was created using a mixture of cDNA of known concentration from all samples being tested. A ratio comparing the relative quantity of the probeset of interest (PS315993) relative to the quantity of the constitutive exon (exon 5) was compared with the splicing index values from the expression arrays to determine replication of findings.
Results
n Folate pathway genes involved in the current study
Our laboratory has profiled the expression levels of over 17,000 transcript clusters in 176 LCLs from the International HapMap CEU and YRI Since many genes undergo alternative splicing and thus may encode proteins with distinct functions [29] , we probed deeper into the folate related genes to determine whether particular transcript isoforms were differentially expressed by comparing the SI using the exon-level The SMARCA2 gene was shown with differential expression between the CEU and YRI (permutated-adjusted p = 0.0019, Figure 2 and table 1). Using samples randomly selected from the two populations (30 CEU and 30 YRI samples), we performed real-time PCR to validate this observation. Gene-expression levels of SMARCA2 in CEU and YRI correlated between the exon expression array for probeset 3159993 and real-time PCR for exon 4-5 (p < 0.0001, Figure 2) . Furthermore, consistent with exon expression array results, exon 4-5 of SMARCA2 was expressed higher in the CEU than in the YRI samples (p < 0.001, T = 3.78, Figure 2) .
In addition, PS2966721 (10th exon) of ASCC3 has significantly higher SI in the CEU than in YRI, implying the shortest transcript 33835000  33830000  33820000  33815000  33810000  33805000   162840000  162850000  162860000  162870000  162880000   33825000   2966648  2966649  2966650  2966651  2966654  2966655  2966657  2966659  2966663  2966674  2966675  2966680  2966681  2966683  2966684  2966687  2966688  2966689  2966690  2966691  2966692  2966694  2966695  2966696  2966697  2966698  2966699  2966700  2966701  2966702  2966703  2966704  2966707  2966714  2966717  2966718  2966721  2966723  2966726  2966727  2966728  2966729  2966730  2966737  2966738  2966745  2966747 Expression of the folate pathway genes ReseaRch aRticle isoforms of ASCC3 may be less common in the YRI (Figure 3a) . Figure 3b illustrates PS3929740 (3´-UTR) for the GART gene with significantly higher SIs in the YRI than in the CEU, suggesting the shortest transcript isoform of GART is expressed more frequently in the YRI than in the CEU. The alternative splicing patterns of the exons and UTRs can be complex. As shown in Figure 3C , IFIH1 gene probesets have a race-specific SI pattern. The longer transcript isoform of IFIH1 gene is likely to be more common in the YRI, while the shorter isoform is more common in the CEU. Note that, 39 probesets within 11 genes with known alternative splicing events in the probesettargeting segments have differential splicing indices between the CEU and the YRI (table 2) .
n eQTL of the differential expressed genes & differential spliced probesets
To identify potential genetic regulators of population specific gene-expression and alternative splicing, we performed genome-wide association studies on 12 genes and 60 probesets in the combined CEU and YRI population samples. As shown in table 3, FPGS gene and ten probesets of seven genes were significantly associated with one or more SNPs (p < 3.2 × 10 -8 , Bonferroni corrected p < 0.05). Among them, we identified two local associations for the probesets of IFIH1 and RUVBL2. As an example illustrated in Figure 4 , the proportion of SMARCA2 transcript isoforms containing the 28th exon to the total gene transcript is higher in the YRI than in the CEU samples. And two ethnic SNPs 3159959  3159976  3159979  3159981  3159982  3159983  3159986  3159988  3159989  3159993  3159995  3159997  3160000  3160001  3160003  3160005  3160006  3160007  3160008  3160009  3160010  3160013  3160014  3160016  3160017  3160018  3160021  3160023  3160032  3160033  3160037  3160042  3160043  3160044  3160045  3160062  3160065  3160073  3160074  3160075  3160078  3160079  3160082  3160085  3160086 (rs6544781 and rs405945; F st = 0.14 and 0.21) are shown to be distantly-associated with the differentially spliced exons in the two population samples (Figure 4) , suggesting that alternative splicing events are under genetic control and likely heritable [30] .
Discussion
The majority of folate pathway genes (46 of 52) are expressed in the LCLs, suggesting that this in vitro model may be useful in studying folate pathway genes or cellular sensitivity to anti folates. Of the 46 folate pathway genes in LCLs, two and ten genes are expressed to a greater extent in the CEU and YRI as measured by exon array, respectively. Seven of these 12 genes have at least one probeset (exon-level) with a higher splicing index in the samples from one population compared with the other. When evaluating alternative splicing, we found that approximately half of the total expressed genes were found to have at least one higher spliced probeset that was more common in one of the populations, suggesting that the different contents of the transcript isoforms may help explain the differential expression levels of the folate pathway genes between these two populations. Besides the 52 folate pathway genes, there are other folate related genes evaluated in this study, such as folate transporter genes (SLC19A1, SLC19A2 and SLC19A3), folate receptor genes (FOLR1, FOLR2 and FOLR1P), folate hydrolase genes (FOLH1 and FOLH2). FOLR1P is not probed on the array, and FOLH1, FOLR2 and SLC19A3 are not expressed. However, we did not find the remaining genes to be differentially expressed nor did we find spliced probesets within these genes (data not shown). Folate pathway genes are often studied in the context of pharmacogenetics of antifolate drugs, such as methotrexate [31] . In this study, we evaluated both transcript-level expression and exonlevel alternative splicing events between different ethnic populations. We identified 60 probesets with differential splicing indices in 23 genes in the two distinct populations. According to the University California, Santa Cruz (UCSC) Genome Browser [32] , 39 of these 60 probesets were shown to be alternatively spliced (table 2) . However, 21 probesets residing in 13 genes demonstrate potential alternative splicing events that have not been reported yet. For example, DHFR, a key gene in the folate pathway, is represented by ten core probesets. Although DHFR gene expression is not different between the two populations, one probeset (PS2864625) in its 3´-UTR is more highly expressed (sevenfold) in the YRI population samples (Supplementary Figure 1) than its neighbor probeset (PS2864626). Given that two known DHFR transcript isoforms share the same 3´-UTR, it is plausible that one or more undetected DHFR transcript isoforms exist by selectively splicing out the tiny 3´-UTR targeted by PS2864626. Another possible explanation is that the hybridization of the PS2864626 is affected by unknown SNPs within the target mRNA sequences; although we have filtered out one potentially affected probe (probe 1864244) of PS2864626 using the latest SNP database (NCBI dbSNP129) [17] . More evidence needs to be collected to confirm whether there is a cryptic splicing site in the 3´-UTR of DHFR and whether this affects the genetic regulation mediated by microRNA [33] .
It is noteworthy that the majority of the regulatory SNPs identified in this study are defined as distant eQTL, suggesting that the regulatory effect on the target genes is in trans. This may involve distant-acting molecules, such as noncoding RNAs [34] . In the process of maturation of pre-mRNA, changes in alternative splicing events has been implicated in several human genetic diseases [35] [36] [37] . Although we identified potential differentially spliced exons and UTRs in folate-related genes, the functional significance of these differential alternative splicing patterns are unknown. Population differences in blood folate level may be a result of differences in alternative splicing.
Severe folate deficiency has been reported to be significantly associated with the susceptibility of multiple diseases including cancer [38] , cardiovascular diseases [38] and neurodegenerative disorders [39] . Recent studies of the folate pathway genes have focused on expression [13] or SNPs within candidate folate pathway genes [40] . The exon level alternative splicing patterns have not been fully investigated. We performed a genomewide ana lysis to identify SNPs associated with genes found to be differentially expressed or with differential splicing indices between the populations. Since racial disparities of folate nutrition status, metabolism and incidence of folate responsive diseases exists [27, 41, 42] , our results are likely to provide clues on the genetic contribution to interethnic differences observed.
In summary, we have compared the gene expression and alternative splicing of folate pathway genes between European and African descendants. The knowledge gained from the present study provides evidence for interethnic future science group Expression of the folate pathway genes ReseaRch aRticle differences in expression and alternative splicing of folate related genes. These results may propel research in the fields of genetic epidemiology of folate-related diseases and the pharmacogenetics of antifolates.
Future perspective
In the present study, we identified folate pathway genes with both transcript-level expression differences and potential alternative splicing differences within samples from two distinct populations. This work provides guidance for further research evaluating the role of differential expressed genes in disease risk and in sensitivity of cells to antifolate drugs, such as pemetrexed and methotrexate.
